Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06921148 · ClinicalTrials.gov registry record · NA
Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy
A NA study of Wound Healing, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06921148: Recruiting NA study of Wound Healing, sponsored by Indiana University.
NCT06921148 is a NA study of Wound Healing that is actively recruiting participants, run by Indiana University. The registered enrollment target is 50 participants, roughly in line with the 53-participant average among 11 other Wound Healing trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06921148, a NA study of Wound Healing, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate the utility of Silk bioprotein, an FDA-approved and readily available post-surgical dressing, as a wound dressing for patients undergoing double-incision mastectomy for female-to-male gender affirmation surgery.
Primary Outcome
This outcome will assess the incidence and time point postoperatively of MARSIs in both dressing types (Silk and Dermabond/Prineo) used on the chest walls of patients enrolled in this study. This will be determined via physical examination and photo documentation of patient surgical incisions.
Conditions Studied
Interventions
- DEVICE Sylk Wound Dressing
- DEVICE Dermabond/Prineo Dressing
Study Locations (1)
Indiana
- Indiana University Health - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-04-30 |
| Est. Completion | 2026-06-14 |
| Phase | NA |
What NCT06921148 shows while recruiting
NCT06921148 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, roughly in line with the 53-participant average among 11 other Wound Healing trials with a reported enrollment target.
The record links to 1 condition, with Wound Healing appearing as the primary indexed condition, and to 2 interventions - of which Sylk Wound Dressing is the first listed.
NCT06921148 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT06921148 about?
NCT06921148 is a clinical study titled "Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy". This study will investigate the utility of Silk bioprotein, an FDA-approved and readily available post-surgical dressing, as a wound dressing for patients undergoing double-incision mastectomy for female-to-male gender affirmation surgery.
What is the current status of trial NCT06921148?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-04-30. Estimated completion is 2026-06-14.
What conditions does trial NCT06921148 study?
This clinical trial studies the following conditions: Wound Healing.
What interventions are being tested in trial NCT06921148?
The interventions under investigation include: Sylk Wound Dressing (DEVICE), Dermabond/Prineo Dressing (DEVICE).
Who is sponsoring clinical trial NCT06921148?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06921148 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound Healing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06921148's enrollment target sits among peer trials
50 4th of 11 higher than 8 of 11 other Wound Healing trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wound Healing trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing
RECRUITING · NA
-
NPWT Reduction Mammaplasty
RECRUITING · NA
-
Assessment Of Infrared Photobiotherapy for Improved Wound Healing
COMPLETED · NA
-
Clinical Study Evaluating Wound Closure With Endoform™ and Symphony™
COMPLETED · NA
-
Determinants of Bone Dimensional Changes After Extraction and Alveolar Ridge Preservation
RECRUITING
-
Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI